Converus

What Converus does

Converus, Inc. is a privately held credibility-assessment technology company founded in 2009 as Credibility Assessment Technologies LLC and rebranded in 2013, headquartered in Lehi, Utah. It commercializes the oculomotor deception test (ODT), originally conceived in 2002 by Dr. John Kircher at the University of Utah, which uses high-speed infrared cameras to capture involuntary eye behaviors — pupil dilation, gaze fixation, blinks, and reading patterns — during structured True/False question sessions. These signals are scored via logistic regression equations to produce a proprietary Converus Credibility Score (1–49 deception, 50–99 credibility) that incorporates population base rates for posterior probability calibration.

The company sells three core products. EyeDetect is a hardware-anchored station used by trained administrators in law enforcement, corrections, government, private security, financial services, and corporate settings, with reported accuracy of 86–88% for screening and 87% for diagnostic tests. EyeDetect+, launched in 2023, is described as the world's first automated polygraph, combining oculomotor measurement with Physio Tracker physiological sensors (electrodermal, cardiovascular, respiration, body movement, cuff-less blood pressure) and reporting 89–91% accuracy. VerifEye, launched in 2023, is a patent-pending mobile application for iOS and Android that enables approximately 10-minute self-administered truth-verification tests via a smartphone camera at 80–84% accuracy.

Converus does not sell directly to end consumers; instead, it distributes through a 100+ authorized service partner network across 40+ countries, supplemented by direct enterprise and government sales. The Converus Dashboard provides a web-based business intelligence interface for test administration, reporting, and account management. Revenue mechanics combine software/hardware licensing (EyeDetect stations) with subscription or test-credit access for VerifEye, supported by a training, certification, and partner-onboarding program. The science team, anchored by Kircher and David Raskin, has produced 24+ peer-reviewed publications since 2009, and EyeDetect was admitted as evidence under a Daubert motion in New Mexico in 2018.

Name

Converus

Legal name

Converus, Inc.

Website

https://converus.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Converus provides scientifically validated credibility assessment technology — oculomotor and physiological deception-detection products (EyeDetect, EyeDetect+, VerifEye) — sold through a 100+ authorized service partner network to law enforcement, corrections, government, financial services, and corporate customers worldwide.

Ownership category

akta.pro rank

Headquarters

HQ city

Lehi

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain

Revenue model

1. EyeDetect Software Licenses: Organizations purchase or license EyeDetect testing software and stations to conduct in-person credibility assessments through authorized service providers.
2. VerifEye App Distribution: VerifEye is available as a free mobile app with test credits or subscription-based access for organizations sending tests to candidates via text or email.
3. EyeDetect+ Automated Polygraph: Sale and licensing of EyeDetect+ automated polygraph system with Physio Tracker sensors for organizations requiring polygraph-based testing.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Converus develops and licenses credibility assessment (lie detection) technologies built on oculomotor deception detection. Its flagship products are EyeDetect (computer-based eye tracking test), EyeDetect+ (automated polygraph combining eye tracking with physiological sensors), and VerifEye (smartphone app for remote truth verification), supported by the Converus Dashboard for test management. The products are delivered to end users through a global network of over 100 authorized service partners as well as direct sales to enterprise and government clients.

Product overview

Converus provides a suite of credibility assessment (lie detection) products. The core portfolio consists of EyeDetect (eye-tracking-based computer test, 86-88% accuracy), EyeDetect+ (automated polygraph combining eye-tracking with physiological sensors, 89-91% accuracy), and VerifEye (mobile smartphone app, 80-84% accuracy). All products are supported by the Converus Dashboard for centralized test result management. EyeDetect measures involuntary eye behaviors via camera; EyeDetect+ adds polygraph sensors for enhanced accuracy; VerifEye enables mobile self-administered testing. The company was founded in 2009 as Credibility Assessment Technologies LLC, renamed Converus in 2013, and is headquartered in Lehi, Utah.

Differentiator

Problem solved

Functional benefit

Brands

• VerifEye: App-based testing solution requiring a test link sent to a cell phone with an average accuracy of 80 to 84%. Available for iOS and Android phones.

Products and services

• EyeDetect Computer-based credibility assessment test that measures involuntary eye behaviors (pupil diameter, eye movements, blinks, fixations, reading behavior) using a high-speed infrared camera while participants answer True/False questions on a computer. Achieves 86-88% accuracy for screening tests in 15-30 minutes, with results delivered in under 5 minutes. Fully automated and examiner-bias-free; available in 50+ languages.
• EyeDetect+ Automated polygraph combining EyeDetect oculomotor measures with Physio Tracker multi-channel physiological sensors (electrodermal activity, cardiovascular activity, respiration activity, body movements, and cuff-less blood pressure). Achieves 89-91% accuracy over 20-45 minute test sessions; intended for organizations needing higher-confidence credibility assessments than EyeDetect alone.
• VerifEye Mobile app-based truth verification solution for iOS and Android that measures involuntary eye behavior via the smartphone camera to validate truth in self-administered tests of about 10 minutes. U.S. patent pending; accuracy of 80-84%. Used for employment vetting, identity verification, creditworthiness assessment, and claims verification, with organizations able to send test links to candidates via text or email.
• Converus Dashboard Web-based business intelligence platform that provides authorized users browser-based access to test results within minutes of test completion. Shows examinee name, date/time, test taken, and credibility score, and includes charts, accounts management, test license tracking, and PDF report generation.
• Physio Tracker Multi-channel physiology monitor used with the EyeDetect Station (version 3 or 4) for the EyeDetect+ automated polygraph; sensors attached to fingers, wrists, and abdomen record electrodermal activity, cardiovascular activity, respiration activity, and body movements. Powers via USB cable connected to the EyeDetect Station.

Quantifiable outcome

• EyeDetect screening tests achieve 86-88% accuracy; diagnostic tests achieve 87% accuracy; EyeDetect+ achieves 89-91% accuracy
• +7 more outcomes

Named customers7 records

Segments8 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

Four partnerships are on record, tiered core.

• Authorized Service Partners (Global Network)coreChannel Partner/ Reseller/ DistributorConverus has established a global network of over 100 authorized service partners who administer EyeDetect, EyeDetect+, and VerifEye tests. Partners include polygraph examiners, private investigation firms, security companies, and credibility assessment organizations located across North America, Latin America, Europe, Middle East, Africa, and Asia-Pacific. Partners undergo training and certification to provide testing services.
• University of Utah Science TeamcoreStrategic or Co-development PartnerWorld-renowned scientists at the University of Utah, led by Dr. John Kircher and Dr. David Raskin, developed EyeDetect technology. The Converus Science Team has collaborated on 24+ publications since 2009. Dr. Kircher invented the computerized polygraph in 1991 and continues to lead R&D for new products like EyeDetect+.
• American Polygraph Association (APA)coreStrategic or Co-development PartnerConverus maintains relationships with the APA through participation in seminars and conferences. EyeDetect was tested on 66 polygraph examiners attending the APA seminar in Baltimore in 2016, demonstrating 95.5% accuracy.
• Capital Center for Credibility Assessment (C3A)coreChannel Partner/ Reseller/ DistributorC3A serves as an authorized partner specifically for federal government agencies in the U.S., providing EyeDetect testing services to Fairfax, VA and surrounding areas.

Scale indicators3 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Lafayette Instrument Company: Long-established US manufacturer of traditional polygraph and credibility assessment instruments serving law enforcement, government, and private examiners. Most direct incumbent competitor to Converus in credibility assessment equipment.
• Limestone Technologies: Manufacturer of the Axciton computerized polygraph system used by polygraph examiners worldwide. Direct competitor in automated credibility assessment with overlapping computerized scoring technology and similar examiner/government customer base.
• Nemesysco: Israeli developer of Layered Voice Analysis technology for voice-based deception detection. Competes with Converus in the credibility assessment market using a different physiological modality (voice vs. eye-tracking) for similar law enforcement, government, and enterprise use cases.
• Stoelting: US manufacturer of polygraph instruments and psychological assessment equipment serving polygraph examiners, researchers, and clinical professionals. Overlaps directly with Converus's polygraph examiner segment and credibility assessment category.

Emerging players

• Smart Eye (Affectiva): Emotion AI company (acquired Affectiva in 2021) analyzing facial and eye behavior to detect cognitive and emotional states. Closest technology analog to Converus's oculomotor detection with broader automotive and market research applications; potential competitor in credibility assessment via eye-tracking.
• HireVue: AI-powered video interview and assessment platform for hiring and talent evaluation. Serves overlapping enterprise HR/employment assessment customers and could integrate credibility assessment features that compete with EyeDetect's pre-employment use case.
• Realeyes: Emotion AI company using facial coding and eye tracking to measure attention and emotion for advertising effectiveness and market research. Adjacent technology competitor with overlapping eye-tracking methodology but focused on marketing vs. Converus's credibility assessment focus.
• Pymetrics: Behavioral assessment platform using neuroscience-based games and AI for hiring and talent management (now part of Harver). Serves overlapping enterprise HR customers as Converus's pre-employment screening solution, though using cognitive games rather than eye-tracking deception detection.

Broad incumbents

• Validity Screening Solutions: Established employment screening company offering background checks, drug testing, and verification services. Larger incumbent in the broader pre-employment screening market where Converus's EyeDetect pre-employment solution competes or could partner.
• Sterling Check: Large global background screening and identity verification company serving enterprise and government clients. While primarily focused on traditional background checks, represents an established incumbent that could expand into credibility assessment or serve as a distribution partner for Converus's enterprise solutions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ConverusInc
• YouTubeyoutube.com/user/ConverusInc
• Facebookfacebook.com/converusinc
• LinkedInlinkedin.com/company/converus
• Instagraminstagram.com/converus.inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds9 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Converus